InSightec set to bring ExAblate to Japan

By staff writers

November 25, 2014 -- MR-guided focused ultrasound (MRgFUS) developer InSightec has received approval from Japan's Ministry of Health, Labor, and Welfare for its ExAblate MRgFUS system.

The clearance covers the use of ExAblate for pain palliation caused by bone metastases and for advanced treatment of uterine fibroids, according to InSightec shareholder Elbit Imaging. GE Healthcare holds the approval for ExAblate and will distribute the system in Japan, Elbit said.

Copyright © 2014

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking